Sumitovant Biopharma, Inc. 401(K) Plan — Form 5500 plan (Sumitovant Biopharma, Inc.)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Sumitovant Biopharma, Inc. 401(K) Plan is a benefit plan reported by Sumitovant Biopharma, Inc. under EIN 84-3508458 and plan number 001. The latest loaded filing year is 2023. The filing reports 646 participants and $0 in end-of-year plan assets, where available in the loaded dataset.
Key reported metrics
- Plan sponsor
- Sumitovant Biopharma, Inc.
- EIN
- 84-3508458
- Plan number
- 001
- Plan type
- 2
- Location
- New York, NY
- Latest filing year
- 2023
- Participants
- 646
- End-of-year plan assets
- $0
Form 5500 filing history
| Filing year | Participants | Schedules | Filing |
|---|---|---|---|
| 2023 | 646 | H, C | 20241009105137NAL0010538691001 |
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $0
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $0
- Net assets (BOY)
- $42,607,365
Income & contributions
- Employer contributions
- $5,335,772
- Participant contributions
- $7,489,622
- Total contributions
- $15,679,533
- Total income / additions
- $21,412,131
Expenses & distributions
- Benefits paid
- $1,077,392
- Administrative expenses
- $105,070
- Total expenses
- $1,185,976
- Net increase / (decrease)
- $20,226,155
Service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. | Year |
|---|---|---|---|---|
| Nfp | INVESTMENT ADVISOR | $64,000 | not reported in the loaded dataset | 2023 |
| Fidelity Investments Institutional | RECORDKEEPER | $41,070 | $0 | 2023 |